NCT05049902 - Bismuth-containing Quadruple Therapy for Helicobacter Pylori Eradication | Biotech Hunter

Enrollment

1,300

Participants

Timeline

Start Date

September 21, 2021

Primary Completion Date

May 30, 2023

Study Completion Date

June 30, 2023

Conditions

Helicobacter Pylori Infection

Interventions

DRUG

Amoxicillin

Use according to the drug combination options selected by each center.

DRUG

Clarithromycin

Use according to the drug combination options selected by each center.

DRUG

Tetracycline

Use according to the drug combination options selected by each center.

DRUG

Metronidazole

Use according to the drug combination options selected by each center.

DRUG

Bismuth Potassium Citrate

Use according to the drug combination options selected by each center.

DRUG

Colloidal Bismuth Pectin

Use according to the drug combination options selected by each center.

DRUG

Vonoprazan fumarate

Use according to the drug combination options selected by each center.

Trial Locations (6)

257000

Qilu hosipital, Jinan

Unknown

Jiangsu Province Hospital, Nanjing

Maternity and Child Care Health Center of Dezhou, Dezhou

Heze Municipal 3rd people's hospital, Heze

PKUCare Luzhong Hospital, Zibo

The People's Hospital of Jimo.Qingdao, Qingdao

All Listed Sponsors

collaborator

Maternity and Child Care Health Center of Dezhou

UNKNOWN

collaborator

Heze Municipal 3rd people's hospital

UNKNOWN

collaborator

Peking University Care Luzhong Hospital

OTHER

collaborator

The People's Hospital of Jimo.Qingdao

UNKNOWN

lead

Shandong University

OTHER